U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C4H4O6.Fe
Molecular Weight 203.916
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FERROUS TARTRATE

SMILES

[Fe++].O[C@H]([C@@H](O)C([O-])=O)C([O-])=O

InChI

InChIKey=OHZCFWMJMWFNFP-ZVGUSBNCSA-L
InChI=1S/C4H6O6.Fe/c5-1(3(7)8)2(6)4(9)10;/h1-2,5-6H,(H,7,8)(H,9,10);/q;+2/p-2/t1-,2-;/m1./s1

HIDE SMILES / InChI

Molecular Formula C4H4O6
Molecular Weight 148.071
Charge -2
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula Fe
Molecular Weight 55.845
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Iron(II) gluconate (also known as a ferrous gluconate) is used in the treatment of hypochromic anemia. The real problem of iron therapy is not the theoretical utilization of iron, or the reticulocyte response, or even the daily increase of hemoglobin. These are important only as they indicate the return of the patients' blood to normal in a reasonably short time without undue inconvenience. Most patients suffering from hypochromic anemia respond well to most forms of iron when administered in adequate dosage. For the patients who cannot tolerate the usual iron compounds, it is important to have a medication which is effective and which causes minimum disturbance. Ferrous gluconate is such a medicament.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Unknown

Approved Use

Unknown
Palliative
Unknown

Approved Use

Unknown
Primary
Ferro Sanol Duodenal

Approved Use

Ferro Sanol is an iron substitute in case of latent or manifest iron deficiency with and without development of anaemia.
PubMed

PubMed

TitleDatePubMed
THE USE OF FERROUS GLUCONATE IN THE TREATMENT OF HYPOCHROMIC ANEMIA.
1937 Jul
Clinical appraisal of drugs with special reference to a new chelate hematinic.
1957 Jul 11
[FERROUS ASPARTATE IN THERAPY].
1964 Jan 1
Decreased treatment failure rates following duodenal release ferrous glycine sulfate in iron deficiency anemia associated with autoimmune gastritis and Helicobacter pylori gastritis.
2007
Bioleaching of heavy metals from sewage sludge by indigenous iron-oxidizing microorganisms using ammonium ferrous sulfate and ferrous sulfate as energy sources: a comparative study.
2009 Nov 15
The effect of iron treatment on adhesion molecules in patients with iron deficiency anemia.
2010 Dec
Tolerability of different oral iron supplements: a systematic review.
2013 Apr
Effect of abomasal ferrous lactate infusion on phosphorus absorption in lactating dairy cows.
2013 Jul
A practical and successful desensitization protocol for immediate hypersensitivity reactions to iron salts.
2014
Synthesis of phosphabenzenes by an iron-catalyzed [2+2+2] cycloaddition reaction of diynes with phosphaalkynes.
2015 Jun 22
Continuous sulfidogenic wastewater treatment with iron sulfide sludge oxidation and recycle.
2017 May 1
Patents

Sample Use Guides

Unknown
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:46:59 UTC 2023
Edited
by admin
on Fri Dec 15 16:46:59 UTC 2023
Record UNII
ZRW631PTZD
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FERROUS TARTRATE
MART.   WHO-DD  
Common Name English
FERROUS TARTRATE [MART.]
Common Name English
FERRUM TARTARICUM
HPUS  
Common Name English
Ferrous tartrate [WHO-DD]
Common Name English
IRON(II) TARTRATE
Systematic Name English
TARTARIC ACID, IRON(2+) SALT (1:1)
Common Name English
FERRUM TARTARICUM [HPUS]
Common Name English
IRON TARTRATE (FE(C4H4O6))
Common Name English
BUTANEDIOIC ACID, 2,3-DIHYDROXY- (2R,3R)-, IRON(2+) SALT (1:1)
Common Name English
Classification Tree Code System Code
WHO-ATC B03AA08
Created by admin on Fri Dec 15 16:46:59 UTC 2023 , Edited by admin on Fri Dec 15 16:46:59 UTC 2023
WHO-VATC QB03AA08
Created by admin on Fri Dec 15 16:46:59 UTC 2023 , Edited by admin on Fri Dec 15 16:46:59 UTC 2023
Code System Code Type Description
PUBCHEM
6451676
Created by admin on Fri Dec 15 16:46:59 UTC 2023 , Edited by admin on Fri Dec 15 16:46:59 UTC 2023
PRIMARY
FDA UNII
ZRW631PTZD
Created by admin on Fri Dec 15 16:46:59 UTC 2023 , Edited by admin on Fri Dec 15 16:46:59 UTC 2023
PRIMARY
DRUG BANK
DB13639
Created by admin on Fri Dec 15 16:46:59 UTC 2023 , Edited by admin on Fri Dec 15 16:46:59 UTC 2023
PRIMARY
EPA CompTox
DTXSID301019697
Created by admin on Fri Dec 15 16:46:59 UTC 2023 , Edited by admin on Fri Dec 15 16:46:59 UTC 2023
PRIMARY
SMS_ID
100000078494
Created by admin on Fri Dec 15 16:46:59 UTC 2023 , Edited by admin on Fri Dec 15 16:46:59 UTC 2023
PRIMARY
ChEMBL
CHEMBL3707386
Created by admin on Fri Dec 15 16:46:59 UTC 2023 , Edited by admin on Fri Dec 15 16:46:59 UTC 2023
PRIMARY
CAS
2944-65-2
Created by admin on Fri Dec 15 16:46:59 UTC 2023 , Edited by admin on Fri Dec 15 16:46:59 UTC 2023
PRIMARY
DRUG CENTRAL
4545
Created by admin on Fri Dec 15 16:46:59 UTC 2023 , Edited by admin on Fri Dec 15 16:46:59 UTC 2023
PRIMARY
ECHA (EC/EINECS)
220-950-1
Created by admin on Fri Dec 15 16:46:59 UTC 2023 , Edited by admin on Fri Dec 15 16:46:59 UTC 2023
PRIMARY
EVMPD
SUB13879MIG
Created by admin on Fri Dec 15 16:46:59 UTC 2023 , Edited by admin on Fri Dec 15 16:46:59 UTC 2023
PRIMARY
WIKIPEDIA
Ferrous tartrate
Created by admin on Fri Dec 15 16:46:59 UTC 2023 , Edited by admin on Fri Dec 15 16:46:59 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY